Cardiac Biotech Solutions, Inc. (CBSC)
0.0303
0.00 (0.00%)
USD |
OTCM |
Oct 27, 16:00
Cardiac Biotech Solutions Cash from Operations (Quarterly) : -0.1918M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1918M |
| March 31, 2026 | -0.0545M |
| December 31, 2025 | -0.1822M |
| September 30, 2025 | -0.2589M |
| June 30, 2025 | -0.1411M |
| March 31, 2025 | |
| December 31, 2024 | -0.2047M |
| September 30, 2024 | -0.1815M |
| June 30, 2024 | -0.1613M |
| March 31, 2024 | -0.5082M |
| December 31, 2023 | -0.1239M |
| September 30, 2023 | -0.3666M |
| June 30, 2023 | -0.2467M |
| March 31, 2023 | -0.1236M |
| December 31, 2022 | -0.2915M |
| September 30, 2022 | -0.4125M |
| June 30, 2022 | -0.3594M |
| March 31, 2022 | 13.56M |
| December 31, 2021 | -0.2896M |
| September 30, 2021 | -0.1278M |
| June 30, 2021 | -0.1471M |
| Date | Value |
|---|---|
| March 31, 2021 | -0.3241M |
| December 31, 2020 | -0.1057M |
| September 30, 2020 | 0.0923M |
| June 30, 2020 | -0.3252M |
| March 31, 2020 | -0.6106M |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | -0.0028M |
| March 31, 2019 | -0.0587M |
| December 31, 2018 | -0.006M |
| September 30, 2018 | -0.1103M |
| June 30, 2018 | 0.0663M |
| March 31, 2018 | -0.6651M |
| December 31, 2017 | -0.2009M |
| September 30, 2017 | 0.0999M |
| June 30, 2017 | -0.0025M |
| March 31, 2017 | 0.031M |
| December 31, 2016 | -0.0704M |
| September 30, 2016 | -0.0086M |
| June 30, 2016 | -0.0144M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Vyome Holdings, Inc. | -0.9037M |
| Abbott Laboratories | -- |
| AngioDynamics, Inc. | -15.33M |
| Alphatec Holdings, Inc. | 20.51M |
| AtriCure, Inc. | 22.19M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.19M |
| Free Cash Flow | -0.6874M |
| Free Cash Flow Per Share (Quarterly) | -0.0012 |
| Free Cash Flow to Equity (Quarterly) | -0.1818M |
| Free Cash Flow to Firm (Quarterly) | -0.1714M |
| Free Cash Flow Yield | -13.72% |